In last trading session, NLS Pharmaceutics Ltd (NASDAQ:NLSP) saw 1.49 million shares changing hands with its beta currently measuring -0.38. Company’s recent per share price level of $2.38 trading at $0.38 or 19.00% at ring of the bell on the day assigns it a market valuation of $5.88M. That closing price of NLSP’s stock is at a discount of -922.69% from its 52-week high price of $24.34 and is indicating a premium of 27.31% from its 52-week low price of $1.73. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.46 million shares which gives us an average trading volume of 349.10K if we extend that period to 3-months.
For NLS Pharmaceutics Ltd (NLSP), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 3.00. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0 in the current quarter.
NLS Pharmaceutics Ltd (NASDAQ:NLSP) trade information
Upright in the green during last session for gaining 19.00%, in the last five days NLSP remained trading in the green while hitting it’s week-highest on Thursday, 12/19/24 when the stock touched $2.38 price level, adding 14.7% to its value on the day. NLS Pharmaceutics Ltd’s shares saw a change of -89.91% in year-to-date performance and have moved 21.43% in past 5-day. NLS Pharmaceutics Ltd (NASDAQ:NLSP) showed a performance of -25.16% in past 30-days. Number of shares sold short was 84932.0 shares which calculate 0.15 days to cover the short interests.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 7.15% during past 5 years.
NLS Pharmaceutics Ltd (NASDAQ:NLSP)’s Major holders
BVF INC/IL is the top institutional holder at NLSP for having 5.75 million shares of worth $1.25 million. And as of 2024-06-30, it was holding 15.0543 of the company’s outstanding shares.
The second largest institutional holder is ARMISTICE CAPITAL, LLC, which was holding about 2.31 million shares on 2024-06-30. The number of shares represents firm’s hold over 6.0535 of outstanding shares, having a total worth of $0.5 million.
